According to interim findings from two early-stage trials, a booster dose of Johnson & Johnson’s vaccine significantly raised antibody levels, the firm reported on Wednesday. Binding antibody levels were nine times greater following a second dose of the J&J single-dose vaccination than they were 28 days after the first dose. Binding antibodies, unlike neutralising antibodies, which kill the virus, adhere to it but do not eliminate it or prevent infection.
According to interim findings from two early-stage trials, a booster dose of Johnson & Johnson’s vaccine significantly raised antibody levels, the firm reported on Wednesday. Binding antibody levels were nine times greater following a second dose of the J&J single-dose vaccination than they were 28 days after the first dose. Binding antibodies, unlike neutralising antibodies, which kill the virus, adhere to it but do not eliminate it or prevent infection.
